Resultados de la búsqueda

Bryniarski K, Fernández-Messina L, Askenase PW, Nazimek K. Editorial: Extracellular vesicles as potent modulators of immunity. Front Cell Dev Biol (2023) 11:1278498
Link to the full text in Repisalud

Gómez IJ, Ovejero-Paredes K, Méndez-Arriaga JM, Pizúrová N, Filice M, Zajíčková L, Prashar S, Gómez-Ruiz S. Organotin(IV)-Decorated Graphene Quantum Dots as Dual Platform for Molecular Imaging and Treatment of Triple Negative Breast Cancer. Chemistry (2023) 29:e202301845

Bermúdez-Jiménez FJ, Carriel V, Santos-Mateo JJ, Fernández A, García-Hernández S, Ramos KA, Piqueras-Flores J, Cabrera-Romero E, Barriales-Villa R, de la Higuera Romero L, Alcalá López JE, Gimeno Blanes JR, Sánchez-Porras D, Campos F, Alaminos M, Oyonarte-Ramírez JM, Álvarez M, Tercedor L, Brodehl A, Jiménez-Jáimez J. ROD2 domain filamin C missense mutations exhibit a distinctive cardiac phenotype with restrictive/hypertrophic cardiomyopathy and saw-tooth myocardium. Rev Esp Cardiol (2023) 76:301-311

Raposeiras-Roubín S, Abu-Assi E, Fernández Sanz T, Barreiro Pardal C, Muñoz Pousa I, Melendo Viu M, Domínguez Erquicia P, Ledo Piñeiro A, Lizancos Castro A, González Bermúdez I, Rosselló X, Ibáñez B, Íñiguez Romo A. Bleeding and embolic risk in patients with atrial fibrillation and cancer. Rev Esp Cardiol (2023) 76:344-352

Sanchis J, Avanzas P, Filgueiras-Rama D, García-Pavía P, Sanchis L. Revista Española de Cardiología 2022. Rev Esp Cardiol (2023) 76:370-378

de Frutos F, Gonzalez-Lopez E. New challenges in the management of patients with transthyretin cardiac amyloidosis: beyond oral anticoagulation. Rev Esp Cardiol (2023) S1885-5857:00031-2

Barreiro-Pérez M, Pueyo PP, Roubin SR, Corominas DM, Uribarri A, Bachiller RE, Rozado Castaño J, Álvarez LG, Fernández LS, Domínguez F, Figal DP. Consenso de expertos sobre el diagnóstico y el tratamiento de la miocarditis asociada con infección o vacunación contra el SARS-CoV-2 [Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management]. Rev Esp Cardiol (2023) 76:555-563
Link to the full text in Repisalud

Porres-López E, de Frutos F, Silva-Hernández L, Galán L, González-López E, García-Pavía P. Hereditary transthyretin amyloidosis caused by p.Ser43Asn variant. A new endemic variant in Ecuador. Rev Esp Cardiol (2023) S1885-5857(23)00045-2

González-Gómez A, Fernández-Golfín C, Hinojar R, Monteagudo JM, García A, García-Sebastián C, García-Lunar I, Sánchez-Recalde Á, Salido L, Pardo A, Zamorano JL. The 4A classification for patients with tricuspid regurgitation. Rev Esp Cardiol (2023) 76:845-851

Pascual-Figal D, Lax A, Asensio López MC. Circulating ST2, from biomarker to pathogenic mediator. Rev Esp Cardiol (2023) S1885-5857(23)00102-0
Link to the full text in Repisalud